CWM
MYOV

Concentrum Wealth Management’s Myovant Sciences Ltd. MYOV Stock Holding History

Concentrum Wealth Management’s Portfolio MYOV Stock Details MYOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-11,875
Closed -$266K – 67
2021
Q3 		$266K Sell
11,875
-2,735
-19% -$60K 0.17% 52
2021
Q2 		$333K Hold
14,610
– – 0.21% 44
2021
Q1 		$301K Hold
14,610
– – 0.23% 38
2020
Q4 		$404K Buy
14,610
+2,125
+17% +$41.4K 0.32% 32
2020
Q3 		$175K Buy
+12,485
New +$232K 0.17% 40

Other funds holding MYOV

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Concentrum Wealth Management's MYOV Position: Q4 2021 in Review

Concentrum Wealth Management sold out of Myovant Sciences Ltd. (MYOV) in Q4 2021, closing a stake of 11,875 shares — an estimated $266K sold.

Concentrum Wealth Management first reported a position in MYOV in Q3 2020 and held it in 5 quarters. The position peaked at $404K in Q4 2020. 110 funds tracked by Wall St. Rank hold MYOV as of Q4 2021.

  • Concentrum Wealth Management reported no remaining Myovant Sciences Ltd. position as of Q4 2021 after selling out during the quarter.
  • Concentrum Wealth Management sold 11,875 Myovant Sciences Ltd. shares in Q4 2021, an estimated $266K.
  • Concentrum Wealth Management first reported a position in Myovant Sciences Ltd. in Q3 2020 and held it in 5 quarters.
  • Concentrum Wealth Management's Myovant Sciences Ltd. position peaked at $404K in Q4 2020.
  • 110 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q4 2021.

Based on Concentrum Wealth Management's 13F filing for Q4 2021, filed 2 Feb 2022.